Publication - Impact assessment

Genomics in Scotland strategy: business and regulatory impact assessment

Published: 28 June 2024
Directorate: Chief Operating Officer, NHS Scotland Directorate
Topic: Business, industry and innovation, Education, Health and social care, +1 more … Work and skills
ISBN: 9781836014348

Business and regulatory impact assessment (BRIA) for the Genomics in Scotland: Building our Future five-year national strategy (2024 to 2029).

Supporting documents

14. Summary and Recommendation

It is recommended that the strategy is implemented as it will aid continuity, development, reform, and improvement of genomic medicine across Scotland and improve outcomes for people in Scotland, regardless of where they live. The strategy will be monitored by the Genomics Policy Team, with support and oversight from the SSNGM, and they will provide the Cabinet Secretary for NHS Recovery, Health and Social Care with regular updates on progress.

Contact

Email: holly.ennis@gov.scot

There is a problem

Thanks for your feedback

Was this helpful?

Yes

Your comments

Your feedback helps us to improve this website. Do not give any personal information because we cannot reply to you directly.

Choose a reason for your feedback

Your comments

Your feedback helps us to improve this website. Do not give any personal information because we cannot reply to you directly.

Yes, but

Choose a reason for your feedback

Your comments

Your feedback helps us to improve this website. Do not give any personal information because we cannot reply to you directly.

Information

14. Summary and Recommendation

Contact

There is a problem